BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Oxford Asymmetry drug discovery based
on genomics research
Oxford
Glycosciences plc.
Peptide
Therapeutics
Group plc.
Perlegen
Sciences Inc.
Perlegen
Sciences Inc.
Phyton Inc. (now
Phyton Biotech
Inc.)
OGS' proteomics
technology to identify
disease-specific
proteins as potential
diagnostics, clinical
markers and drug
targets in Alzheimer's
disease
Peptide's broad
spectrum allergy
vaccine for veterinary
market
identification of genes
associated with major
diseases
discovery of genes
using Perlegen's DNA
sample preparation
R&D agreement
(3/95), extended for
one year, Pfizer will
pay £5.4M over
three years
$50M research
collaboration--Pfizer
invested in OGS'
IPO and will fund
research for two
years
development
agreement--Pfizer
will have exclusive
option to worldwide
license and will pay
costs of research
and clinical
development for
evaluating the
vaccine
four-year research
agreement
research
collaboration
collaborative
development
agreement
Copyright ©2006 AHC Media ® 314
4/97
4/98
1/98
12/05
12/02
1996
Phytopharm plc. obesity drug collaboration and
licence agreement
8/98
Renovis Inc. research, development worldwide
5/05
and commercialization collaboration and
of small molecules that
target VR1
licensing agreement
Repligen Corp. growth factor inhibitors research
collaboration,
Repligen received
milestone payment
(12/97)
12/95
Repligen Corp. small molecule
research
1/97
compounds that
stimulate immune
system responses
collaboration
Rigel
development of inhaled research and 1/05
Pharmaceuticals products for allergic licensing agreement
Inc.
asthma and other
respiratory diseases
Sangamo
Sangamo's zinc finger research agreement 1/05
BioSciences Inc. DNA binding protein
technology for use in
Pfizer's mammalian
cell- based protein
pharmaceutical
production
Schering AG Schering's ADP
receptor antagonist
program
licensing agreement 2/05
Schwarz Pharma fesoterodine licensing agreement 6/06